Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07602218 · ClinicalTrials.gov registry record · NA
Adaptive Decision Support for Addiction Treatment (ADAPT) Serial Randomized Testing for Usability, Round 2
A NA study, sponsored by Yale University.
- Not yet
- Registry status
- NA
- Development phase
- 300
- Enrollment target
NCT07602218 is a NA study that has not yet begun recruiting, run by Yale University. The registered enrollment target is 300 participants.
The verdict
NCT07602218, a NA study, has not yet begun recruiting, sponsored by Yale University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
Study Summary
This study is stage 2, round 2 of a larger study which refines and optimizes the EMBED clinical decision support (CDS); see NCT03658642 to increase number of ED physicians following standard of care for the administration of buprenorphine to appropriate patients with opioid use disorder.
Interventions
- OTHER Refined EMBED CDS
- OTHER Provider alert to order consultation with addiction counselor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2026-05-21 |
| Est. Completion | 2026-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07602218
The ClinicalTrials.gov registry entry for NCT07602218 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Refined EMBED CDS is the first listed.
NCT07602218 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07602218 about?
NCT07602218 is a clinical study titled "Adaptive Decision Support for Addiction Treatment (ADAPT) Serial Randomized Testing for Usability, Round 2". This study is stage 2, round 2 of a larger study which refines and optimizes the EMBED clinical decision support (CDS); see NCT03658642 to increase number of ED physicians following standard of care for the administration of buprenorphine to appropriate patients with opioid use disorder.
What is the current status of trial NCT07602218?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2026-05-21. Estimated completion is 2026-08.
What interventions are being tested in trial NCT07602218?
The interventions under investigation include: Refined EMBED CDS (OTHER), Provider alert to order consultation with addiction counselor (OTHER).
Who is sponsoring clinical trial NCT07602218?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.